NO150837C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive xanten- og tioxantenderivater - Google Patents
Analogifremgangsmaate ved fremstilling av terapeutisk aktive xanten- og tioxantenderivaterInfo
- Publication number
- NO150837C NO150837C NO791592A NO791592A NO150837C NO 150837 C NO150837 C NO 150837C NO 791592 A NO791592 A NO 791592A NO 791592 A NO791592 A NO 791592A NO 150837 C NO150837 C NO 150837C
- Authority
- NO
- Norway
- Prior art keywords
- group
- groups
- effects
- formula
- carbon atoms
- Prior art date
Links
- -1 dimethylsulphamoyl group Chemical group 0.000 abstract 4
- 125000004432 carbon atom Chemical group C* 0.000 abstract 3
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 abstract 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 2
- 125000004043 oxo group Chemical group O=* 0.000 abstract 2
- 229910052760 oxygen Inorganic materials 0.000 abstract 2
- 239000001301 oxygen Substances 0.000 abstract 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical group FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 239000005864 Sulphur Substances 0.000 abstract 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 230000007059 acute toxicity Effects 0.000 abstract 1
- 231100000403 acute toxicity Toxicity 0.000 abstract 1
- 150000007933 aliphatic carboxylic acids Chemical class 0.000 abstract 1
- 230000001078 anti-cholinergic effect Effects 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 239000011737 fluorine Chemical group 0.000 abstract 1
- 229910052731 fluorine Inorganic materials 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 230000005923 long-lasting effect Effects 0.000 abstract 1
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 abstract 1
- 230000000701 neuroleptic effect Effects 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000001624 sedative effect Effects 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- RJFHGQWVDZWRTC-UHFFFAOYSA-N thioxanthen-9-one;xanthen-9-one Chemical class C1=CC=C2C(=O)C3=CC=CC=C3OC2=C1.C1=CC=C2C(=O)C3=CC=CC=C3SC2=C1 RJFHGQWVDZWRTC-UHFFFAOYSA-N 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D335/10—Dibenzothiopyrans; Hydrogenated dibenzothiopyrans
- C07D335/12—Thioxanthenes
- C07D335/14—Thioxanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
- C07D335/18—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Psychiatry (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Polymerisation Methods In General (AREA)
- Inks, Pencil-Leads, Or Crayons (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1931078 | 1978-05-12 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO791592L NO791592L (no) | 1979-11-13 |
| NO150837B NO150837B (no) | 1984-09-17 |
| NO150837C true NO150837C (no) | 1985-01-09 |
Family
ID=10127259
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO791592A NO150837C (no) | 1978-05-12 | 1979-05-11 | Analogifremgangsmaate ved fremstilling av terapeutisk aktive xanten- og tioxantenderivater |
Country Status (14)
| Country | Link |
|---|---|
| US (3) | US4285956A (de) |
| EP (1) | EP0005607B1 (de) |
| JP (1) | JPS54154772A (de) |
| AT (1) | ATE5141T1 (de) |
| AU (1) | AU522926B2 (de) |
| CA (1) | CA1127648A (de) |
| DE (1) | DE2966344D1 (de) |
| DK (1) | DK190179A (de) |
| ES (1) | ES480468A1 (de) |
| FI (1) | FI791503A7 (de) |
| IE (1) | IE48261B1 (de) |
| NO (1) | NO150837C (de) |
| NZ (1) | NZ190373A (de) |
| ZA (1) | ZA792250B (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4356184A (en) * | 1980-06-04 | 1982-10-26 | G. D. Searle & Co. | Anti-allergic or antihypertensive 1-piperidinylmethyl benzenamines |
| US4501749A (en) * | 1983-10-31 | 1985-02-26 | Merck & Co., Inc. | Peripherally selective dopamine antagonists in the treatment of ocular hypertension |
| US4777177A (en) * | 1984-10-19 | 1988-10-11 | Ciba-Geigy Corporation | Pesticidal thioxanthen-9-ylidenepiperidines |
| US5250681A (en) * | 1988-06-02 | 1993-10-05 | Ajinomoto Co., Inc. | Piperidine derivatives and hypotensives containing the same |
| US5393890A (en) | 1988-06-02 | 1995-02-28 | Ajinomoto Co., Inc. | Piperidine derivatives and hypotensives containing the same |
| CA2004211A1 (en) * | 1988-11-30 | 1990-05-31 | Masataka Syoji | Piperidine derivatives and hyportensives containing the same |
| US7060711B2 (en) * | 2001-10-25 | 2006-06-13 | Biofrontera Bioscience Gmbh | Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT2B receptor antagonist |
| EP1306376A1 (de) * | 2001-10-25 | 2003-05-02 | Biofrontera Pharmaceuticals AG | Derivaten von 4-(Thio- oder Selenoxanthen-9-yliden)-Piperidin oder Acridine und ihre Verwendung als selektieven 5-HT2B antagonisten |
| AU2004253898A1 (en) | 2003-06-27 | 2005-01-13 | Janssen Pharmaceutica N.V. | Tricyclic delta opioid modulators |
| WO2007030089A1 (en) | 2004-08-05 | 2007-03-15 | Janssen Pharmaceutica N.V. | Tricyclic delta- opioid modulators |
| MX2007007625A (es) * | 2004-12-22 | 2008-01-28 | Johnson & Johnson | Moduladores delta-opioides triciclicos. |
| EA011674B1 (ru) * | 2004-12-22 | 2009-04-28 | Янссен Фармацевтика Н.В. | ТРИЦИКЛИЧЕСКИЕ δ-ОПИОИДНЫЕ МОДУЛЯТОРЫ |
| BRPI0519201A2 (pt) | 2004-12-22 | 2008-12-30 | Janssen Pharmaceutica Nv | moduladores de delta-opiàide tricÍclico |
| AU2006203880A1 (en) * | 2005-01-06 | 2006-07-13 | Janssen Pharmaceutica N.V. | Tricyclic delta-opioid modulators |
| JP2008543866A (ja) * | 2005-06-16 | 2008-12-04 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 三環式オピオイドモジュレーター |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3470188A (en) * | 1967-01-05 | 1969-09-30 | Smithkline Corp | 9-cycloalkyl-lower alkyl-piperidylidene derivatives of xanthenes and thioxanthenes |
| US3974285A (en) * | 1974-04-10 | 1976-08-10 | Merck & Co., Inc. | 10,11-Furo-derivatives of cyproheptadine |
| US4086350A (en) * | 1974-11-06 | 1978-04-25 | Smithkline Corporation | Pharmaceutical compositions and method of producing anti-psychotic activity without extrapyramidal symptoms |
| US4031222A (en) * | 1975-12-22 | 1977-06-21 | Merck & Co., Inc. | Trifluoromethylthio (and sulfonyl) derivatives of cyproheptadine analogs |
| US4073912A (en) * | 1976-10-12 | 1978-02-14 | Smithkline Corporation | Piperidylidene derivatives of benzo-fused xanthenes, thioxanthenes and dibenzoxepins and antipsychotic use thereof |
-
1979
- 1979-05-03 US US06/035,735 patent/US4285956A/en not_active Expired - Lifetime
- 1979-05-04 EP EP79300778A patent/EP0005607B1/de not_active Expired
- 1979-05-04 AT AT79300778T patent/ATE5141T1/de not_active IP Right Cessation
- 1979-05-04 DE DE7979300778T patent/DE2966344D1/de not_active Expired
- 1979-05-04 NZ NZ190373A patent/NZ190373A/xx unknown
- 1979-05-09 DK DK190179A patent/DK190179A/da unknown
- 1979-05-09 ZA ZA792250A patent/ZA792250B/xx unknown
- 1979-05-10 AU AU46941/79A patent/AU522926B2/en not_active Ceased
- 1979-05-10 FI FI791503A patent/FI791503A7/fi not_active Application Discontinuation
- 1979-05-11 NO NO791592A patent/NO150837C/no unknown
- 1979-05-11 ES ES480468A patent/ES480468A1/es not_active Expired
- 1979-05-11 CA CA327,464A patent/CA1127648A/en not_active Expired
- 1979-05-12 JP JP5764079A patent/JPS54154772A/ja active Pending
- 1979-08-08 IE IE1105/79A patent/IE48261B1/en unknown
- 1979-12-21 US US06/106,353 patent/US4275209A/en not_active Expired - Lifetime
- 1979-12-21 US US06/105,985 patent/US4309429A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| AU4694179A (en) | 1979-11-15 |
| AU522926B2 (en) | 1982-07-01 |
| US4309429A (en) | 1982-01-05 |
| NO791592L (no) | 1979-11-13 |
| EP0005607B1 (de) | 1983-10-26 |
| US4275209A (en) | 1981-06-23 |
| ZA792250B (en) | 1980-08-27 |
| ATE5141T1 (de) | 1983-11-15 |
| EP0005607A1 (de) | 1979-11-28 |
| FI791503A7 (fi) | 1981-01-01 |
| CA1127648A (en) | 1982-07-13 |
| NZ190373A (en) | 1981-12-15 |
| NO150837B (no) | 1984-09-17 |
| DE2966344D1 (en) | 1983-12-01 |
| IE791105L (en) | 1979-11-12 |
| ES480468A1 (es) | 1980-07-01 |
| JPS54154772A (en) | 1979-12-06 |
| IE48261B1 (en) | 1984-11-14 |
| DK190179A (da) | 1979-11-13 |
| US4285956A (en) | 1981-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO150837C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive xanten- og tioxantenderivater | |
| SE7905402L (sv) | Fenyl-piperazinderivat | |
| SE8000920L (sv) | 4-(naftylmetyl)piperidinderivat | |
| SE7601206L (sv) | Acetylenderivat | |
| ES450166A1 (es) | Procedimiento de preparacion de nuevos derivados de amino- benzociclohepteno. | |
| GB1114335A (en) | 10-substituted-10,11-dihydrodibenzo[b,f]thiepine-5-oxides and-5,5-dioxides and process for the preparation thereof | |
| DK5086A (da) | Aminoalkylsubstituerede urinstofderivater og enantiomere | |
| SE7603951L (sv) | Forfarande for framstellning av 7-alfa-(4-hydroci-1,5-nafthydrin-3karbonamido)alfa-fenylacetamido-cefalosporinderivat | |
| SE8202845L (sv) | Nya produkter, derivat av 2-amino-tiazolyl -2-oxiimino-acetamido-bicyklo-oktenkarboxylsyra, sett for framstellning derav, anvendning derav sasom lekemedel, kompositioner innehallande dem och nya erhallna mellanprodukter | |
| NO802925L (no) | Nitrosoureaderivater og fremgangsmaate ved fremstilling derav | |
| SE7714372L (sv) | Nya foreningar med farmakologisk aktivitet | |
| ES497635A0 (es) | Procedimiento para la preparacion de compuestos cefemicos | |
| SE8005493L (sv) | 4-(haftalenyloxi)piperidin-derivat | |
| SE8703494L (sv) | Mellanprodukter anvendbara vid framstellning av 2-tiofen-ettiksyraderivat | |
| SE7606497L (sv) | Substituerade 4-fenylimidazoliner, deras syraadditinossalter och forfarande for framstellning derav | |
| DE3766286D1 (de) | Heteropolyzyklische aromatische verbindungen. | |
| DK575188D0 (da) | Additionsprodukter af 3,4-dihydro-4-oxo-2h-1,2-benzothiazin-3-carboxylsyre1,1-dioxid-estere og heterocyclisk substituerede aminer | |
| DK215680A (da) | Fremgangsmaade til fremstilling af ciavulansyrederivater | |
| DK279183A (da) | Benzisothiazol- og benzisoxazolpiperazinderivater og fremgangsmaade til fremstilling deraf |